MOLECULAR PROFILING OF TUMORS FOR TRANSLATIONAL & CLINICAL RESEARCH



The intuitive MERCURY™ interface enables users to quickly visualize an accurate and comprehensive molecular tumor profile for cancer patients after rapid analysis of their sequencing data (constitutional tumor DNA and tumor RNA).



MERCURY™ also provides users with access to numerous annotation databases, links to potential clinical trials and treatment options based on identified variants, as well as the ability to create and export a customizable report.

TRANSFORMING SEQUENCING DATA INTO KNOWLEDGE




MERCURY™ IS NOW CUSTOMIZABLE FOR LARGE AND SMALL GENE PANELS



MERCURY™ is now fully adaptable to your data analysis needs with the ability to handle oncology sequencing data ranging from broad sequencing (WES, RNA-Seq, WGS) to large gene panels and all the way to targeted gene panels. Whether you use a third-party panel available on the market or have developed your own, IntegraGen will work with you to customize the data analysis and reporting pipeline for the clinical sequencing you perform.

MERCURY™ TO IDENTIFY DIFFICULT SOMATIC MUTATIONS



en_US